Skip to main content
VulnerabilityPublished Updated

CVE-2026-51901: SuperAGI · Improper Access Control

Affects SuperAGISource CVE Database V5

0

Not known to be exploited · CVSS 8.1 High.

Data as of 26 Oct 2026, 10:12 UTC

CVSS 3.1 base score
8.1High
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.3% chance of exploitation in 30 days – higher than 24% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 2 Oct 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponised: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.

What to do

Affected software

ProductAffectedFixed in
GitHubtransformeroptimus/SuperAGIpkg:github/transformeroptimus/SuperAGIOther threatsAffected
  • <=0.0.14
Fixed in–

Check your own hosts for these packages with threat-finder (opens in a new tab), our free open-source scanner.

AI-suggested

Until a fix is available, restrict access to the affected endpoint and enforce strict organizational access controls where possible to mitigate unauthorized agent scheduling.

Description

SuperAGI versions up to 0.0.14 contain an incorrect access control vulnerability in the /api/agentexecutions/schedule endpoint. Authenticated users can schedule agents belonging to other organizations without proper authorization checks, potentially leading to unauthorized access and control over those agents. This vulnerability has a high severity rating with a CVSS score of 8.1.

References

Community reviews

Loading reviews…